Global drugmakers are lobbying for wealthy nations to fund a supply mechanism that would secure vaccines for low-income countries without delay in case of a new pandemic, but said the proposal was contingent on free cross-border trade.
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) said in a statement on Monday that global pandemic vaccine distribution needs to be put on a new footing because the world’s poorest countries were forced to wait for shots during the current pandemic.
"The industry is willing to reserve an allocation of real-time production for distribution to priority populations in lower income countries, as determined by health authorities during pandemics," said IFPMA director general Thomas Cueni.
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.